Dr. Gary Sibbald is the world-renowned dermatologist who is leading Rimon’s initial clinical trial for its MI-Sorb™ dressing, validating its unique Theramer™ technology. Dr. Sibbald is a co-founder of the Canadian Association of Wound Care (CAWC) and is on the editorial or advisory board of several wound care journals. Lecturing extensively, he is also a prolific author and an educator, sponsoring regular clinics to promote the interdisciplinary approach to wound healing.

Recently, I was given the opportunity to speak with Dr. Sibbald about wound care and the MI-Sorb™ clinical trial. The interview is available to download through the link provided below.